| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/25/1997 | US5614652 Cytotoxic, palladium disposed within an iron oxide matrix |
| 03/25/1997 | US5614611 Humanized monoclonal antibodies binding to IgE-bearing B cells but not basophils |
| 03/25/1997 | US5614587 Collagen-based bioadhesive compositions |
| 03/25/1997 | US5614583 Homogenized flowable hydrogel of crosslinked N-vinyl lactam polymer |
| 03/25/1997 | US5614578 Injection-molded dosage form |
| 03/25/1997 | US5614549 High molecular weight polymer-based prodrugs |
| 03/25/1997 | US5614513 Release agent binder for vitamin d compounds and derivatives |
| 03/25/1997 | US5614506 After angioplasty |
| 03/25/1997 | US5614491 Liquid preparations containing cyclosporin and process for preparing same |
| 03/25/1997 | US5614488 Cytoxic fragment of a peptide toxin |
| 03/25/1997 | US5614487 Sustained release pharmaceutical composition |
| 03/25/1997 | US5614404 Plasmid vector for insertion of human immunodeficiency virus dna sequences into a pox virus |
| 03/25/1997 | US5614221 Method of preparing a drug delivery system comprising a drug and a gel using a syringe |
| 03/25/1997 | US5614220 Core with coating of water soluble enteric coating for release |
| 03/25/1997 | US5614218 Capsule containing morphine salt |
| 03/25/1997 | US5614210 Transdermal device for the delivery of alfuzosin |
| 03/25/1997 | US5614206 Controlled dissolution pellet containing calcium sulfate |
| 03/25/1997 | US5614205 Bioartificial endocrine device |
| 03/25/1997 | US5614199 Inclusion complexes of clavulanic acid and of alkali salts thereof with hydrophilic and hydrophobic β-cyclodextrin derivatives, a process for the preparation thereof and the use thereof |
| 03/25/1997 | US5614191 Antitumor |
| 03/25/1997 | US5614181 Nonionic surfactants derived from 1,2-isopropylidene-3-epoxypropylglycerol and a carboxylic acid and their use |
| 03/25/1997 | US5614178 Compositions for topical delivery of drugs comprising a mixture of high and low HLB surfactants and alkoxylated ether |
| 03/25/1997 | US5614169 Contrast agents, consisting of galactose particles and an amphilic carboxylic acid |
| 03/25/1997 | CA2092287C Controlled release verapamil tablet |
| 03/25/1997 | CA2082523C Non-destructive carriers for cyclodextrin complexes |
| 03/25/1997 | CA2067178C Solid tumor treatment method and composition |
| 03/25/1997 | CA2003379C Fatty emulsion stabilized by a polysaccharide derivative |
| 03/25/1997 | CA1339008C Amphotericin b liposome preparation |
| 03/20/1997 | WO1997010507A1 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
| 03/20/1997 | WO1997010493A1 METHOD FOR MEASURING NITROSYL (FeII)-HEMOGLOBIN |
| 03/20/1997 | WO1997010281A1 Selectively functionalizable desdendrimers |
| 03/20/1997 | WO1997010265A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 03/20/1997 | WO1997010049A1 Oil-water emulsifiers |
| 03/20/1997 | WO1997010005A2 Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response |
| 03/20/1997 | WO1997009989A1 Compositions with anti-apoptotic activity, containing a mixture of phospholipids |
| 03/20/1997 | WO1997009980A1 Pharmaceutical formulations containing darifenacin |
| 03/20/1997 | WO1997009978A1 Use of esters of polyhydric alcohols to enhance the oral bioavailability of drug substances as well as novel esters and pharmaceutical compositions containing them |
| 03/20/1997 | WO1997009974A1 Antiseptic skin care composition and method for making same |
| 03/20/1997 | WO1997009972A1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 03/20/1997 | WO1997009968A1 Oral gel capsule formulation of 1,2,4-benzotriazine oxides |
| 03/20/1997 | WO1997009965A1 A NON-IRRITATING SKIN AND HAIR REJUVENATING COMPOSITION HAVING A pH BETWEEN 1 AND 6.5 |
| 03/20/1997 | WO1997009964A1 Microemulsions for use as vehicles for administration of active compounds |
| 03/20/1997 | WO1997009960A1 Composition and method for treating diseased nails |
| 03/20/1997 | WO1997003700A3 Gamma-interferon activity modulating agent |
| 03/20/1997 | WO1997003654A3 Pharmaceutical compositions |
| 03/20/1997 | CA2232081A1 Antiseptic skin care composition and method for making same |
| 03/20/1997 | CA2232050A1 Method for measuring nitrosyl (feii)-hemoglobin |
| 03/20/1997 | CA2232043A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 03/20/1997 | CA2231840A1 Selectively functionalizable desdendrimers |
| 03/20/1997 | CA2231769A1 Composition and method for treating diseased nails |
| 03/20/1997 | CA2231687A1 Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response |
| 03/20/1997 | CA2229435A1 Compositions with anti-apoptotic activity, containing a mixture of phospholipids |
| 03/19/1997 | EP0763543A2 A method for preparing an inflammatory cytokine (MIP-2) and diagnostic and therapeutic applications for the cytokine or its antibody |
| 03/19/1997 | EP0763362A2 A pharmaceutical base in ointment form and its use |
| 03/19/1997 | EP0763354A1 Oil/water mixture composition |
| 03/19/1997 | EP0763124A1 Method for introducing nucleic acid in higher eukaryotic cells |
| 03/19/1997 | EP0763063A1 Lysozyme-degradable biomaterials |
| 03/19/1997 | EP0763056A1 Stabilization of peptides and proteins for radiopharmaceutical use |
| 03/19/1997 | EP0763051A1 3'-(4'-) nonradioactively tagged nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid spacer |
| 03/19/1997 | EP0762898A1 Cyclodextrin cellular delivery system for oligonucleotides |
| 03/19/1997 | EP0762897A1 Method of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby |
| 03/19/1997 | EP0762896A1 Tocopherol compositions for delivery of biologically active agents |
| 03/19/1997 | EP0762892A1 Diphtheria toxin vaccines bearing a mutated r domain |
| 03/19/1997 | EP0659084B1 Medical preparations containing n-methylated cyclic undecapeptides |
| 03/19/1997 | EP0644755B1 Surface modified nsaid nanoparticles |
| 03/19/1997 | EP0642344B1 Stable hydrated cephalosporin dry powder for oral suspension formulation |
| 03/19/1997 | EP0626974B1 Mitogen-free substance, its preparation and its use |
| 03/19/1997 | EP0617610B1 Suspension aerosol formulations |
| 03/19/1997 | EP0566590B1 Particulates |
| 03/19/1997 | CN1145586A Taste masked composition containing a drug/polymer complex |
| 03/19/1997 | CN1145582A Low pH, hydrolytically stable, cosmetic compsn. containing acidic actives |
| 03/19/1997 | CN1145372A Low-odor, higher molecular weight polyether polyols, process for producing them, and their use for production of polumers, cosmetics and pharmaceutial products synthesized from polyether polyols |
| 03/19/1997 | CN1145365A Camptothecin derivatives |
| 03/19/1997 | CN1145359A Application of salicylic acid derivative used as oil-in-water emulsion |
| 03/18/1997 | US5612460 Active carbonates of polyalkylene oxides for modification of polypeptides |
| 03/18/1997 | US5612382 Transdermal drug delivery using a hydroxy alkyl amide |
| 03/18/1997 | US5612376 Topically applying 3-phenyllactic acid to human skin |
| 03/18/1997 | US5612367 Method of enhancing bioavailability of pharmaceutical agents |
| 03/18/1997 | US5612361 Apparatus for removing components from solutions |
| 03/18/1997 | US5612327 1α,24-(OH)2 -cholecalciferol emulsion composition and method for treating psoriasis |
| 03/18/1997 | US5612315 Pharmaceutical growth hormone formulations |
| 03/18/1997 | US5612313 Controlled-pH formulation for intravesicular instillation of TGFαPE40 ab |
| 03/18/1997 | US5612202 Process for the non-random cleavage of starch and the low D.E. starch conversion products produced thereby |
| 03/18/1997 | US5612185 Method for identifying tumor cells in cell cycle arrest |
| 03/18/1997 | US5612056 Transdermal formulations |
| 03/18/1997 | US5612053 Polysaccharide gum carrier |
| 03/18/1997 | US5612052 Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof |
| 03/18/1997 | US5612043 Oil-in-water emulsion containing a perfluoropolyether, composition containing the same, preparation process and use in cosmetics and dermatology |
| 03/18/1997 | US5612034 Super-globuling for in vivo extended lifetimes |
| 03/18/1997 | US5612032 Method for diagnosing tumors using mouse monoclonal antibodies |
| 03/18/1997 | US5612027 Eye surgery and maintaining pupil size by administering an acidic viscoelastic polymer |
| 03/18/1997 | US5612026 Anion exchange resin, xanthan gum, water soluble salt |
| 03/18/1997 | US5612016 Conjugates of antibodies and bifunctional ligands |
| 03/18/1997 | US5611464 Container for preserving media in the tip of a solution dispenser |
| 03/18/1997 | CA2072559C Method for making liposomes of enhanced entrapping capacity toward foreign substances to be encapsulated |
| 03/18/1997 | CA2037101C Omeprazole compositions designed for administration in rectum |
| 03/13/1997 | WO1997009068A2 Interactive molecular conjugates |
| 03/13/1997 | WO1997009055A1 Isolation of microdomains of caveolae and gpi-anchored proteins |
| 03/13/1997 | WO1997009052A1 Therapeutic azide compounds |
| 03/13/1997 | WO1997009036A2 Improved pharmaceutical ion exchange resin composition |